Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro.

Saved in:
Bibliographic Details
Title: Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro.
Authors: Santos IA; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom., Grosche VR; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.; Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University, São Jose do Rio Preto, Brazil., Cassani NM; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom., Veneziani RCS; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil., Ribeiro GL; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil., Bastos JK; Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Nicolau-Junior N; Institute of Biotechnology, Federal University of Uberlândia (UFU), Uberlândia, Brazil., Merits A; Institute of Bioengineering, University of Tartu, Tartu, Estonia., Martins CHG; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil., Harris M; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom., Jardim ACG; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Source: Frontiers in microbiology [Front Microbiol] 2025 May 09; Vol. 16, pp. 1540934. Date of Electronic Publication: 2025 May 09 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40415937
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Santos+IA%22">Santos IA</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Grosche+VR%22">Grosche VR</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.; Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University, São Jose do Rio Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Cassani+NM%22">Cassani NM</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Veneziani+RCS%22">Veneziani RCS</searchLink>; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil.<br /><searchLink fieldCode="AU" term="%22Ribeiro+GL%22">Ribeiro GL</searchLink>; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil.<br /><searchLink fieldCode="AU" term="%22Bastos+JK%22">Bastos JK</searchLink>; Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Nicolau-Junior+N%22">Nicolau-Junior N</searchLink>; Institute of Biotechnology, Federal University of Uberlândia (UFU), Uberlândia, Brazil.<br /><searchLink fieldCode="AU" term="%22Merits+A%22">Merits A</searchLink>; Institute of Bioengineering, University of Tartu, Tartu, Estonia.<br /><searchLink fieldCode="AU" term="%22Martins+CHG%22">Martins CHG</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.<br /><searchLink fieldCode="AU" term="%22Harris+M%22">Harris M</searchLink>; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jardim+ACG%22">Jardim ACG</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548977%22">Frontiers in microbiology</searchLink> [Front Microbiol] 2025 May 09; Vol. 16, pp. 1540934. <i>Date of Electronic Publication: </i>2025 May 09 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548977 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-302X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221664302X%22">1664302X </searchLink><i>NLM ISO Abbreviation: </i>Front Microbiol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40415937
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmicb.2025.1540934
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1540934
    Titles:
      – TitleFull: Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Santos IA
      – PersonEntity:
          Name:
            NameFull: Grosche VR
      – PersonEntity:
          Name:
            NameFull: Cassani NM
      – PersonEntity:
          Name:
            NameFull: Veneziani RCS
      – PersonEntity:
          Name:
            NameFull: Ribeiro GL
      – PersonEntity:
          Name:
            NameFull: Bastos JK
      – PersonEntity:
          Name:
            NameFull: Nicolau-Junior N
      – PersonEntity:
          Name:
            NameFull: Merits A
      – PersonEntity:
          Name:
            NameFull: Martins CHG
      – PersonEntity:
          Name:
            NameFull: Harris M
      – PersonEntity:
          Name:
            NameFull: Jardim ACG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 05
              Text: 2025 May 09
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1664-302X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in microbiology
              Type: main
ResultId 1